Glaxo Italian Antibiotic Plant Reopening In October After FDA Warning Letter
Executive Summary
Glaxo Wellcome's Italian manufacturing plant will resume production of the injectable antibiotics Zinacef (cefuroxime) and Fortaz (ceftazidime) for shipment to the U.S. in October, the company said following receipt of a warning letter from FDA.